Patent details

Basic Information

Publication number:

EP2805967

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP141756635

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Variants derived from ActRIIB and uses therefor

French Title of Invention:

Variantes derivees de ActRIIB, et leurs utilisations

German Title of Invention:

Aus ActRIIB abgeleitete Varianten und Anwendungen davon

SPC Number:

Dates

Filing date:

04/02/2008

Grant date:

20/04/2016

EP Publication Date:

20/04/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/11/2014

EP B1 Publication Date:

20/04/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

04/02/2017

Expiration date:

04/02/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/02/2008

 

 

Name:

Acceleron Pharma Inc.

Address:

128 Sidney Street, Cambridge, MA 02139, United States (US)

Inventor

1

Name:

Knopf John

Address:

United States (US)

2

Name:

Kumar Ravindra

Address:

United States (US)

3

Name:

Seehra Jasbir

Address:

United States (US)

Priority

1

Priority Number:

899304 P

Priority Date:

02/02/2007

Priority Country:

United States (US)

2

Priority Number:

927088 P

Priority Date:

01/05/2007

Priority Country:

United States (US)

3

Priority Number:

931880 P

Priority Date:

25/05/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 14/705;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages